Analytical Strategies for Busulfan Quantification: A Review of HPLC Method Development and Validation
Description
The bifunctional alkylating agent busulfan is still a necessary medication for the palliative treatment of chronic myeloid leukemia (CML) and pre-transplant conditioning regimens. Because of its varied pharmacokinetic profile and narrow therapeutic index, accurate quantification in pharmaceutical formulations and biological matrices is essential for therapeutic monitoring. Because of its exceptional selectivity, sensitivity, and repeatability, high-performance liquid chromatography (HPLC) has become the most used analytical method for this purpose. An extensive summary of recent advancements in HPLC method design, optimization, and validation for busulfan is provided by this review and experimental investigation. Busulfan’s physicochemical and pharmacological characteristics are covered, along with analytical techniques such as HPLC and LC-MS/MS and forced degradation tests demonstrating stability-indicating nature. The developed method used water, acetonitrile, and tetrahydrofuran (30:65:5, v/v/v) with UV detection at 280 nm, validated as per ICH Q2 (R1) guidelines